Cinitapride is a gastroprokinetic agent with serotonergic activity, used to treat various gastrointestinal motility disorders. It is primarily prescribed for:
∙ Gastroesophageal reflux disease (GERD)
∙ Functional dyspepsia
∙ Irritable bowel syndrome (IBS) with predominant bloating or delayed gastric emptying
Cinitapride acts as a 5-HT₄ receptor agonist, a 5-HT₂ antagonist, and a dopamine D₂ antagonist, facilitating gastric emptying and improving esophageal and intestinal motility. This triple action improves both upper GI symptoms (like heartburn and bloating) and gastric discomfort.
It is usually administered orally in tablet form, typically before meals.
Parent: Cinitapride / Cinitapride Tartrate
Cinitapride impurities can arise from chemical synthesis, degradation during storage, or formulation processes, and must be controlled under ICH guidelines to ensure drug safety and effectiveness.
Process-Related Impurities
Degradation Impurities
Elemental Impurities
Analytical Techniques for Impurity Detection
Cinitapride is used to treat gastrointestinal disorders such as:
Cinitapride has a multi-receptor mechanism:
Common side effects include: